KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) EBITDA (2016 - 2025)

Zoetis (ZTS) has disclosed EBITDA for 13 consecutive years, with $1.0 billion as the latest value for Q2 2025.

  • On a quarterly basis, EBITDA rose 600.98% to $1.0 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $1.4 billion, a 31.35% decrease, with the full-year FY2025 number at -$487.0 million, down 41.57% from a year prior.
  • EBITDA was $1.0 billion for Q2 2025 at Zoetis, up from $732.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $1.0 billion in Q2 2025 to a low of -$636.0 million in Q2 2021.
  • A 5-year average of $434.5 million and a median of $651.0 million in 2023 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: plummeted 215.22% in 2021, then surged 2069.7% in 2023.
  • Zoetis' EBITDA stood at $560.0 million in 2021, then plummeted by 105.89% to -$33.0 million in 2022, then soared by 2069.7% to $650.0 million in 2023, then grew by 12.62% to $732.0 million in 2024, then soared by 39.62% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EBITDA are $1.0 billion (Q2 2025), $732.0 million (Q4 2024), and -$199.0 million (Q3 2024).